It is with happy tears that I share the following news article with you entitled “Researchers discover a metabolic mechanism for resistant pancreatic cancer.”
As part of our 2010-2011 Seed Grant Program, Andrea Viale, MD, was a recipient of a $50,000 award. His research resulted in a recent publication on the resistance of cells in targeted cancer therapy. With this new information, many potential new therapies will be available for cancer treatment.
Upon receiving the news, Dr. Viale said “I am really grateful to the Hirshberg Foundation for having believed in and supported this study from the beginning when experimental data were few and weak. Your support was critical for this research. We are strongly committed to move these findings toward the clinic and improve the outcome of such a dreadful disease.”
Our next grant cycle begins on August 15, 2014 and we expect to receive 50 qualified applicants requesting funding for novel studies. Please help us keep up the outstanding momentum of research discoveries that will change the outcome of a pancreatic cancer diagnosis. Our mission is to save lives and with your support our dream will become a reality!
Sincerely,
Agi Hirshberg
Founder
